INSIGHTS ON DRUG DEVELOPMENT
-
Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives
By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.
-
Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease
Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.
-
This Is Where Quality Starts
Quality takes shape long before a workcell ships. Meet the people and processes that ensure consistent performance through every stage of development, and explore how to build reliability into each step.
-
Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety
Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.
-
Enhancing Drug Performance Through Lipid-Based Formulations For CNS Indication3/11/2026
Advance CNS-penetrant therapies by optimizing oral formulations to improve bioavailability, stabilize the API, and deliver more consistent and reliable drug exposure.
-
Validation Provider Shortens The Path To Equipment Qualification8/19/2025
Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.
-
Color Consistency In UHMWPE Medical Textiles3/26/2026
Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.
-
Take Action On PFAS To Protect Your Critical Processes9/18/2025
PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
-
Coordinated Development As An Execution Framework6/9/2026
See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.
DRUG DEVELOPMENT SOLUTIONS
-
Are you using obsolete or aging instruments simply because they continue to work? Running your laboratory with outdated technology brings about challenges beyond just headaches. Older technology may limit your performance, increase your costs, and open your lab up to risk. It may be time to investigate the real cost of using obsolete technology.
With the Waters FlexUP Technology Renewal Program, always work with the latest technology for optimum productivity and security.
-
LMD 6 Laser Microdissection Microscope
Dissection Perfection
Laser Microdissection (LMD, also known as Laser Capture Microdissection or LCM) enables users to isolate specific single cells or entire areas of tissue. Powered by a unique laser design and dynamic software, Leica LMD systems allow users to easily isolate Regions of Interest (ROI) from entire areas of tissue down to single cells or even subcellular structures such as chromosomes.
LMD is typically used in genomics (DNA), transcriptomics (mRNA, miRNA), proteomics, metabolomics, and even next generation sequencing (NGS). Researchers in neurology, cancer research, plant analysis, forensics or climate research rely on this method. Furthermore, LMD is a perfect tool for live cell culture (LCC), for cloning and re-cultivation, manipulation or downstream analysis.
We move the laser, not the sample. And we use gravity for collection. That is why our LMD systems provide you with perfectly cut, contamination-free, analysis-ready dissectates.
-
In the pharmaceutical industry, every capsule and tablet begins with a concept. Transforming that idea into a tangible product requires an expert manufacturing partner. Natoli stands out as a leader in pharmaceutical equipment and services, providing a comprehensive journey from formulation to full-scale production.
-
We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.
-
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.